An observational study in Hip Arthritis and Knee Arthritis, sponsored by Northumbria Healthcare NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-18.
Sponsored by Northumbria Healthcare NHS Foundation Trust · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The ARC Study is a national observational cohort study to investigate patient reported and clinical outcomes after hip and knee replacements. The study has the following objectives:
Participants are recruited and consented online. Patients are invited to participate by collaborating surgical teams nationally in outpatient clinics at the time of being added to a waiting list, in addition to an advertising campaign to recruit patients. They are directed to an online portal where they will be able to review further information.
Consent and data collection is completed electronically through patients entering data online. Baseline demographics and characteristics are recorded, including details of socio-demographics, lifestyle, health status and patient reported outcome measures (PROMs). Patients then undergo hip/knee replacement and postoperative rehabilitation according to the standard care and protocols of the hospital and the preferences of their treating surgeon.
Follow-up data, including PROMs, is collected via online questionnaires up to two years following surgery. The study will ultimately also enable multiple trials to be embedded within the cohort study, using a 'Trials within Cohorts' (TwiCs) methodology.
Northumbria Healthcare NHS Foundation Trust is the lead sponsor of 16 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
UK Residents age 18 years or over undergoing elective primary hip or knee replacement
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Participants must meet all of the inclusion criteria:
Exclusion Criteria:
Provided a participant meets all of the inclusion criteria, there are no exclusion criteria for the cohort study.
Procedure: Hip/Knee Replacement
Hip/Knee Replacement
EQ-5D-5L health-related quality of life score
Time frame: 2 years
PROMIS-10
Patient-Reported Outcomes Measurement Information System Global Health
Time frame: 2 years
Oxford Hip Score
Time frame: 2 years
Oxford Knee Score
Time frame: 2 years
Musculoskeletal Health Questionnaire
MSK-HQ
Time frame: 2 years
Hospital for Special Surgery Hip/Knee Replacement Expectations Surveys
Perception of success/fulfilment of expectations
Time frame: 2 years
Patient Health Questionnaire-4
PHQ-4
Time frame: 2 years
11-point Numerical Pain Rating Scale
Pain
Time frame: 2 years
Pain Catastrophising Scale
Time frame: 2 years
Length of stay
Self-reported by study specific electronic questionnaire
Time frame: 2 years
Activity
Levels of exercise and activity self-reported by study specific electronic questionnaire
Time frame: 2 years
Return to work
Work status self-reported by electronic questionnaire using National Statistics Socio-economic Classification
Time frame: 2 years
Readmission within 30 days
Time frame: 30 days
Surgical Site Infection
Time frame: 2 years
Periprosthetic Fracture
Time frame: 2 years
Dislocation
Time frame: 2 years
Revision/Re-operation
Time frame: 2 years
Mortality
Time frame: 2 years
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2023 (actual). Primary completion is estimated for May 2030, 82 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Northumbria Healthcare NHS Foundation Trust